Literature DB >> 32710208

Comparative Efficacy and Safety of Intravenous Verapamil and Diltiazem for Rate Control in Rapidly Conducted Atrial Fibrillation and Atrial Flutter.

Furqan A Rajput1, Lianlian Du2, Richard J Chappell2, Theodore J Berei3, Zachary D Goldberger3, Jennifer M Wright3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32710208      PMCID： PMC7728829          DOI： 10.1007/s11606-020-06051-2

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   5.128


× No keyword cloud information.
  5 in total

1.  An international view of how recent-onset atrial fibrillation is treated in the emergency department.

Authors:  Carly Rogenstein; Anne-Maree Kelly; Suzanne Mason; Sandra Schneider; Eddy Lang; Catherine M Clement; Ian G Stiell
Journal:  Acad Emerg Med       Date:  2012-11       Impact factor: 3.451

Review 2.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.

Authors:  Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy
Journal:  J Am Coll Cardiol       Date:  2014-03-28       Impact factor: 24.094

3.  Comparison of intravenous diltiazem and verapamil for the acute treatment of atrial fibrillation and atrial flutter.

Authors:  B G Phillips; A J Gandhi; C A Sanoski; V L Just; J L Bauman
Journal:  Pharmacotherapy       Date:  1997 Nov-Dec       Impact factor: 4.705

4.  Diltiazem vs. Metoprolol in the Management of Atrial Fibrillation or Flutter with Rapid Ventricular Rate in the Emergency Department.

Authors:  Christian Fromm; Salvador J Suau; Victor Cohen; Antonios Likourezos; Samantha Jellinek-Cohen; Jonathan Rose; John Marshall
Journal:  J Emerg Med       Date:  2015-04-22       Impact factor: 1.484

5.  Efficacy and safety of intravenous diltiazem for treatment of atrial fibrillation and atrial flutter. The Diltiazem-Atrial Fibrillation/Flutter Study Group.

Authors:  D M Salerno; V C Dias; R E Kleiger; V H Tschida; R J Sung; M Sami; L V Giorgi
Journal:  Am J Cardiol       Date:  1989-05-01       Impact factor: 2.778
  5 in total
  1 in total

Review 1.  An Updated Review on the Role of Non-dihydropyridine Calcium Channel Blockers and Beta-blockers in Atrial Fibrillation and Acute Decompensated Heart Failure: Evidence and Gaps.

Authors:  Jeffrey Triska; Juan Tamargo; Biykem Bozkurt; Uri Elkayam; Addison Taylor; Yochai Birnbaum
Journal:  Cardiovasc Drugs Ther       Date:  2022-03-31       Impact factor: 3.727
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.